Jackie Y.

Jackie Y. has a diverse work experience in various roles and companies.

In 2014, they started as a Lab Assistant at UC San Diego Health, where they worked until 2015.

In 2016, they had a summer internship at GF Securities, where they gained experience in Biotechnology Equity Research.

In 2018, they joined XLP Capital as a Summer Quantitative Analyst in R&D for two months.

Later in 2018, they joined Oppenheimer & Co. Inc. as an Associate Director in Biotechnology Equity Research. Jackie was eventually promoted to Director, a position they held until 2021.

In 2021, Jackie Y. joined RBC Capital Markets as a Senior Associate in Biotechnology Equity Research until 2022.

Currently, they work at aTyr Pharma as a Sr. Manager in Corporate Development, starting in April 2022.

Throughout their career, Jackie Y. has gained expertise in various fields, including lab assistance, quantitative analysis, and biotechnology equity research, showcasing their adaptability and strong knowledge in the industry.

Jackie Y. completed a Bachelor's degree in Marine Biology (Scripps Institution of Oceanography) at UC San Diego from 2013 to 2017. Following this, they pursued a Master's degree in Quantitative Finance at Washington University in St. Louis from 2017 to 2018. In addition to their academic qualifications, Jackie obtained various certifications in the field of finance from FINRA (Financial Industry Regulatory Authority). These certifications include the Series 7 - General Securities Representative Exam Top Off, Series 86, Securities Industry Essentials (SIE) Exam, Series 63 - Uniform Securities Agent State Law Exam, and Series 87. Each certification was obtained in early 2019.